A Phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis
| Image |  |
|---|---|
| Description | scientific article published on 04 August 2020 |
| Author/s |
author: Roger J. Pomerantz Curtis Huttenhower William Jeffery Sandborn |
| Publication date | August 4, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |